Genentech and Roche announced the initiation of three large phase 3 clinical trials evaluating the Port Delivery System with ranibizumab to treat wet age-related macular degeneration and faricimab to treat diabetic macular edema, according to company c…
Author: Healio ophthalmology
Kala submits NDA for topical dry eye treatment KPI-121 0.25%
A new drug application has been submitted to the FDA for KPI-121 0.25%, a topical product candidate for dry eye disease, Kala Pharmaceuticals announced in a press release.KPI-121 0.25%, which utilizes Kala’s Amplify mucus-penetrating drug delivery tech…
DMEK, DSEK have similar graft survival rates in Fuchs’ endothelial corneal dystrophy
Patients with Fuchs’ endothelial corneal dystrophy treated with either Descemet’s membrane endothelial keratoplasty or Descemet’s stripping endothelial keratoplasty experienced similar 5-year graft survival rates, according to a retrospective cohort st…
RightEye eye-tracking system cleared by FDA
RightEye LLC received FDA clearance for its RightEye system for recording, viewing and analyzing eye movements to identify visual tracking impairment.The system tracks eye movements and correlates them to health issues using advanced eye-tracking techn…
VIDEO: Enhancement of Presbyopic IOLs with Refractive Surgery
NEW YORK — From OSN New York 2018, Jennifer Loh, MD, founder of Loh Ophthalmology Associates, gives her presentation on the enhancement of presbyopic IOLs with refractive surgery.
FDA approves Yutiq for chronic noninfectious uveitis
Yutiq, a non-bioerodible intravitreal micro-insert containing 0.18 mg fluocinolone acetonide, received FDA approval for the treatment of chronic noninfectious uveitis affecting the posterior segment of the eye.Nancy Lurker, president and CEO of EyePoin…
VIDEO: Ocular Therapeutix updates product pipeline
NEW YORK — From OSN New York 2018, Antony Mattessich, CEO of Ocular Therapeutix, discusses progress toward approval of the dexamethasone implant, Dextenza, as well as other products in the company’s pipeline.
VIDEO: Lee discusses hot topics from Facial Aesthetics New York
NEW YORK — From Facial Aesthetics New York 2018, course director Wendy W. Lee, MD, discusses some hot topics and techniques that came out of this year’s meeting.
VIDEO: Tips for selecting best premium IOL for cataract surgery
NEW YORK — From OSN New York 2018, John A. Hovanesian, MD, discusses his pearls for selecting the best premium IOLs to use in cataract surgery.
Refractive Surgery Council launches ‘RSC Verified’ patient education program
A new program aimed at educating patients has been launched by the Refractive Surgery Council, according to a press release.The RSC Verified program makes the RSC’s library of patient education material available for surgeons to use on their websites a…
Alcon adds to surgical portfolio
Alcon has added a range of mydriatic, cycloplegic, diagnostic and anesthetic ophthalmic surgical products, according to a press release.These products, transferred from Alcon’s parent company, Novartis, include:“At Alcon, we strive to provide surgeons …
VIDEO: CXL opens new ways to treatment of myopia
VIENNA — At the European Society of Cataract and Refractive Surgeons meeting, Anders Behndig, MD, speaks about a new treatment option for low-grade myopia that uses cross-linking with the aid of oxygen goggles.
VIDEO: Keys to optimize ocular surface before cataract surgery
NEW YORK — From OSN New York 2018, Darrell White, MD, discusses his keys to optimize the ocular surface before cataract surgery, especially in premium and toric IOL implantation.
Enrollment complete in Zimura trial for geographic atrophy
Patient recruitment is complete for a phase 2b clinical trial of Zimura monotherapy for geographic atrophy secondary to dry age-related macular degeneration, Ophthotech announced in a press release.The randomized, double-masked, sham-controlled, multic…
Trump administration says it’s ending ACA ‘sabotage,’ experts say it comes at great risk to patients
The average premium for the second lowest cost silver health insurance plans — the one used to determine final premium tax credits — will drop by a “historical” 1.5% for the first-time since the implementation of the federally-facilitated exchange in 2…
VIDEO: Research investigates impact of Bowman’s layer on corneal biomechanics
VIENNA — At the European Society of Cataract and Refractive Surgeons meeting, Emilio Torres, MD, speaks about his research on the role of Bowman’s layer in corneal biomechanics.
VIDEO: New research might overcome corneal thickness limitations for CXL treatment
VIENNA — At the European Society of Cataract and Refractive Surgeons meeting, Farhad Hafezi, MD, PhD, speaks about a new way of cross-linking extremely thin keratoconic corneas by adapting the fluence individually to the patients’ corneal thickness. A …
Nightstar’s gene therapy for X-linked retinitis pigmentosa shows positive early results
NSR-RPGR, a gene therapy treatment for X-linked retinitis pigmentosa, showed positive preliminary results in a phase 1/2 dose-escalation study, Nightstar Therapeutics announced in a press release.The open-label, dose-ranging, single-eye XIRIUS trial, w…
Young woman presents with binocular diplopia and pain with extraocular movements
A 28-year-old woman presented to the Lahey Eye Clinic reporting a 1-week history of constant binocular, horizontal diplopia. In addition to the diplopia, she described pain with extraocular movements and an associated frontal headache. She denied any b…
Updates in pediatric cataract surgery
Pediatric cataracts may be unilateral or bilateral, congenital or acquired, and represent about 5% to 20% of global pediatric blindness. Pediatric cataract surgery can be challenging both in the operating room and after surgery with regard to clinical …